Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GetGoal-Duo1: Lixisenatide in Type 2 Diabetes
NCT00975286Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2009
- Primary completion
- Aug 2011
- Modality
- Peptides
- Countries
- 26
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Oct 2009; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00975286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975286.